Literature DB >> 2209289

Cell isolation and genotoxicity assessment in gastric mucosa.

D Scott1, M Reuben, G Zampighi, G Sachs.   

Abstract

It has been claimed that in vitro digestion of in vivo DNA-labeled gastric mucosa is suitable for evaluation of genotoxic effects of drugs or chemicals. This method was then used to show that omeprazole (a novel antiulcer drug) was potentially genotoxic. In this study we have examined the method used and the interaction of omeprazole and its derivatives with purified DNA. The method was shown to enrich for dividing cells (6.92 +/- 0.693%, N = 43, 2-hr labeling) in the digest from the intact tissue and was therefore unsuitable for estimating unscheduled DNA synthesis in the gastric mucosa induced by chemicals or drugs including omeprazole. It was further shown that neither omeprazole or its acid-activated product, a cationic sulfenamide, were able to react with isolated purified DNA from either a prokaryote (E. coli) or a eukaryote (salmon sperm). Hence any conclusions using this method attributing acute genotoxic effects to any chemical are based on unrecognized artifacts of the technique and are unsound. In addition, these results negate the suggestion that omeprazole or its gastric metabolites are genotoxic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209289     DOI: 10.1007/bf01536410

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Separation of gastric mucosal cells of rat with proteolytic enzymes, pronase and trypsin, with special reference to the collection, morphology and viability of the generative cells.

Authors:  Y Kurokawa; S Saito; R Kanamaru; T Sato; H Sato
Journal:  Tohoku J Exp Med       Date:  1975-07       Impact factor: 1.848

2.  Genotoxicity studies of gastric acid inhibiting drugs.

Authors:  B Burlinson; S H Morriss; D G Gatehouse; D J Tweats
Journal:  Lancet       Date:  1990-02-17       Impact factor: 79.321

3.  A protocol and guide for the in vivo rat hepatocyte DNA-repair assay.

Authors:  B E Butterworth; J Ashby; E Bermudez; D Casciano; J Mirsalis; G Probst; G Williams
Journal:  Mutat Res       Date:  1987-10       Impact factor: 2.433

4.  Pronase method for isolation of viable cells from Necturus gastric mucosa.

Authors:  A L Blum; G T Shah; V D Wiebelhaus; F T Brennan; H F Helander; R Ceballos; G Sachs
Journal:  Gastroenterology       Date:  1971-08       Impact factor: 22.682

5.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; H Mattsson; L Lundell; F Sundler; G Sundell; B Wallmark; T Watanabe; R Håkanson
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

Review 6.  Regulation of gastrointestinal mucosal growth.

Authors:  L R Johnson
Journal:  Physiol Rev       Date:  1988-04       Impact factor: 37.312

7.  Induction of unscheduled DNA synthesis in rat stomach mucosa by glandular stomach carcinogens.

Authors:  C Furihata; Y Yamawaki; S S Jin; H Moriya; K Kodama; T Matsushima; T Ishikawa; S Takayama; M Nakadate
Journal:  J Natl Cancer Inst       Date:  1984-06       Impact factor: 13.506

8.  Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.

Authors:  P Lorentzon; R Jackson; B Wallmark; G Sachs
Journal:  Biochim Biophys Acta       Date:  1987-02-12

9.  The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.

Authors:  G D Wilson; N J McNally; E Dunphy; H Kärcher; R Pfragner
Journal:  Cytometry       Date:  1985-11

10.  Toxicological studies on omeprazole.

Authors:  L Ekman; E Hansson; N Havu; E Carlsson; C Lundberg
Journal:  Scand J Gastroenterol Suppl       Date:  1985
View more
  7 in total

1.  Antisecretory therapy and genotoxicity.

Authors:  S Holt; R E Powers; C W Howden
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Gastric acid-dependent diseases: a twentieth-century revolution.

Authors:  George Sachs; Jai Moo Shin; Keith Munson; David R Scott
Journal:  Dig Dis Sci       Date:  2014-07       Impact factor: 3.199

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 5.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

6.  Proton-pump inhibitor use does not affect semen quality in subfertile men.

Authors:  Sorena Keihani; James R Craig; Chong Zhang; Angela P Presson; Jeremy B Myers; William O Brant; Kenneth I Aston; Benjamin R Emery; Timothy G Jenkins; Douglas T Carrell; James M Hotaling
Journal:  Asian J Androl       Date:  2018 May-Jun       Impact factor: 3.285

Review 7.  Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer.

Authors:  Márcia Fernanda Correia Jardim Paz; Marcus Vinícius Oliveira Barros de Alencar; Rodrigo Maciel Paulino de Lima; André Luiz Pinho Sobral; Glauto Tuquarre Melo do Nascimento; Cristiane Amaral Dos Reis; Maria do Perpetuo Socorro de Sousa Coêlho; Maria Luísa Lima Barreto do Nascimento; Antonio Luiz Gomes Júnior; Kátia da Conceição Machado; Ag-Anne Pereira Melo de Menezes; Rosália Maria Torres de Lima; José Williams Gomes de Oliveira Filho; Ana Carolina Soares Dias; Antonielly Campinho Dos Reis; Ana Maria Oliveira Ferreira da Mata; Sônia Alves Machado; Carlos Dimas de Carvalho Sousa; Felipe Cavalcanti Carneiro da Silva; Muhammad Torequl Islam; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Oxid Med Cell Longev       Date:  2020-03-28       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.